SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-18-063197
Filing Date
2018-12-06
Accepted
2018-12-06 06:03:41
Documents
1
Period of Report
2019-01-23

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT tv508479-pre14a.htm PRE 14A 482908
  Complete submission text file 0001144204-18-063197.txt   483966
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-13341 | Film No.: 181218621
SIC: 2836 Biological Products, (No Diagnostic Substances)